Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer

od Niyongere, Sandrine, Saltos, Andreas, Gray, Jhanelle E.
izdano v J Thorac Dis (2018)

Temporal trends in demographics and overall survival of non-small cell lung cancer patients at the Moffitt Cancer Center from 1986 to 2008

od Schabath, Matthew B., Thompson, Zachary J., Gray, Jhanelle E.
izdano v Cancer Control (2014)

Targeting Trop-2 in solid tumors: future prospects

od Zaman, Saif, Jadid, Hassan, Denson, Aaron C, Gray, Jhanelle E
izdano v Onco Targets Ther (2019)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer

od Puri, Sonam, Lok, Benjamin H., Leighl, Natasha, Gray, Jhanelle E.
izdano v Front Oncol (2020)

Biomarkers of therapeutic response with immune checkpoint inhibitors

od Bindal, Poorva, Gray, Jhanelle E., Boyle, Theresa A., Florou, Vaia, Puri, Sonam
izdano v Ann Transl Med (2021)

Tobacco-Related Health Disparities Across the Cancer Care Continuum

od Simmons, Vani Nath, Piñeiro, Bárbara, Hooper, Monica Webb, Gray, Jhanelle E., Brandon, Thomas H.
izdano v Cancer Control (2016)

Clinical associations of mucin 1 in human lung cancer and precancerous lesions

od Saltos, Andreas, Khalil, Farah, Smith, Michelle, Li, Jiannong, Schell, Michael, Antonia, Scott J., Gray, Jhanelle E.
izdano v Oncotarget (2018)

Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial

od Chen, Dung-Tsa, Schell, Michael J., Fulp, William J., Pettersson, Fredrik, Kim, Sungjune, Gray, Jhanelle E., Haura, Eric B.
izdano v Transl Cancer Res (2019)

Novel Clinical and Radiomic Predictors of Rapid Disease Progression Phenotypes among Lung Cancer Patients Treated with Immunotherapy: An Early Report

od Tunali, Ilke, Gray, Jhanelle E., Qi, Jin, Abdallah, Mahmoud, Jeong, Daniel K., Guvenis, Albert, Gillies, Robert J., Schabath, Matthew B.
izdano v Lung Cancer (2019)

Phase II Randomized Study of Enzastaurin (LY317615) for Lung Cancer Prevention in Former Smokers

od Gray, Jhanelle E., Altiok, Soner, Alexandrow, Mark G., Walsh, Frank W., Chen, Jian, Schell, Michael J., Tai, Datchen Fritz, Bepler, Gerold
Izdano 2012

Strategies for power calculations in predictive biomarker studies in survival data

od Chen, Dung-Tsa, Huang, Po-Yu, Lin, Hui-Yi, Haura, Eric B., Antonia, Scott J., Cress, W. Douglas, Gray, Jhanelle E.
izdano v Oncotarget (2016)

Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images

od Mu, Wei, Jiang, Lei, Shi, Yu, Tunali, Ilke, Gray, Jhanelle E, Katsoulakis, Evangelia, Tian, Jie, Gillies, Robert J, Schabath, Matthew B
izdano v J Immunother Cancer (2021)

Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance

od Creelan, Ben C., Gray, Jhanelle E., Tanvetyanon, Tawee, Chiappori, Alberto A., Yoshida, Takeshi, Schell, Michael J., Antonia, Scott J., Haura, Eric B.
izdano v Br J Cancer (2019)

A Bayesian pick-the-winner design in a randomized phase II clinical trial

od Chen, Dung-Tsa, Huang, Po-Yu, Lin, Hui-Yi, Chiappori, Alberto A., Gabrilovich, Dmitry I., Haura, Eric B., Antonia, Scott J., Gray, Jhanelle E.
izdano v Oncotarget (2017)

TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer

od Schabath, Matthew B., Giuliano, Anna R., Thompson, Zachary J., Amankwah, Ernest K., Gray, Jhanelle E., Fenstermacher, David A., Jonathan, Kristen A., Beg, Amer A., Haura, Eric B.
Izdano 2013

Dual targeting of WEE1 and PLK1 by AZD1775 elicits single agent cellular anticancer activity

od Wright, Gabriela, Golubeva, Volha, Remsing Rix, Lily L., Berndt, Norbert, Luo, Yunting, Ward, Grace A., Gray, Jhanelle E., Schonbrunn, Ernst, Lawrence, Harshani R., Monteiro, Alvaro N.A., Rix, Uwe
izdano v ACS Chem Biol (2017)

Non-invasive decision support for NSCLC treatment using PET/CT radiomics

od Mu, Wei, Jiang, Lei, Zhang, JianYuan, Shi, Yu, Gray, Jhanelle E., Tunali, Ilke, Gao, Chao, Sun, Yingying, Tian, Jie, Zhao, Xinming, Sun, Xilin, Gillies, Robert J., Schabath, Matthew B.
izdano v Nat Commun (2020)

Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer

od Chen, Dung-Tsa, Chan, Wenyaw, Thompson, Zachary J., Thapa, Ram, Beg, Amer A., Saltos, Andreas N., Chiappori, Alberto A., Gray, Jhanelle E., Haura, Eric B., Rose, Trevor A., Creelan, Ben
izdano v PLoS One (2021)

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small ce...

od Chiappori, Alberto A., Williams, Charles C., Gray, Jhanelle E., Tanvetyanon, Tawee, Haura, Eric B., Creelan, Ben C., Thapa, Ram, Chen, Dung-Tsa, Simon, George R., Bepler, Gerold, Gabrilovich, Dmitry I., Antonia, Scott J.
izdano v Cancer Immunol Immunother (2018)

PAXIP1 potentiates the combination of WEE1 inhibitor AZD1775 and platinum agents in lung cancer

od Jhuraney, Ankita, Woods, Nicholas T., Wright, Gabriela, Rix, Lily, Kinose, Fumi, Kroeger, Jodi L., Remily-Wood, Elizabeth, Cress, W. Douglas, Koomen, John M., Brantley, Stephen G., Gray, Jhanelle E., Haura, Eric B., Rix, Uwe, Monteiro, Alvaro N.
izdano v Mol Cancer Ther (2016)